FIELD: medicine.
SUBSTANCE: invention refers to new compounds which are N-substituted 1,4-diazabicyclo[2.2.2.]octane derivatives. The offered compounds exhibit antiviral activity and can find application in medicine as active components for the development of dosage forms used for treating viral diseases.
EFFECT: higher antiviral activity of the compound.
7 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR INACTIVATION OF VIRUSES EXHIBITING SIMULTANEOUS RIBONUCLEASE, MEMBRANOLYTIC AND ANTIVIRAL ACTIVITIES | 2008 |
|
RU2399388C2 |
| AGENT HAVING ANTIVIRAL ACTIVITY | 2008 |
|
RU2402563C2 |
| AGENT SHOWING ANTIVIRAL ACTIVITY ON DNA-VIRUSES | 2012 |
|
RU2487876C1 |
| AGENT FOR INACTIVATING DNA VIRUSES | 2012 |
|
RU2480478C1 |
| METHOD OF TREATING POULTRY WITH POLYCATIONIC TRIVIRON COMPOUND | 2013 |
|
RU2532355C1 |
| AGENT HAVING ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2443705C1 |
| POLYCATIONIC TRIVIRON COMPOUND AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2527256C1 |
| CIPROFLOXACIN DERIVATIVE WITH ANTIBACTERIAL ACTIVITY AGAINST ANTIBIOTIC-RESISTANT STRAINS OF MICROORGANISMS | 2021 |
|
RU2757741C1 |
| INFLUENZA A VIRUS PROPAGATION INHIBITOR ON BASIS OF COMPLEX OF TITANIUM DIOXIDE NANOPARTICLES AND OLIGONUCLEOTIDE | 2010 |
|
RU2466188C2 |
| NANOCOMPOSITE WITH ACTIVE LIGAND, METHOD OF ITS PREPARATION AND METHOD OF ADDRESS INACTIVATION OF FLU VIRUS INSIDE CELL | 2012 |
|
RU2496878C1 |
